Ventyx Biosciences (VTYX) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free VTYX Stock Alerts $4.98 +0.79 (+18.85%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ventyx Biosciences Short Interest DataCurrent Short Volume8,410,000 sharesPrevious Short Volume8,380,000 sharesChange Vs. Previous Month+0.36%Dollar Volume Sold Short$31.45 millionShort Interest Ratio / Days to Cover2.2Last Record DateApril 30, 2024Outstanding Shares70,500,000 sharesFloat Size56,850,000 sharesShort Percent of Float14.79%Today's Trading Volume1,390,010 sharesAverage Trading Volume918,171 sharesToday's Volume Vs. Average151% Short Selling Ventyx Biosciences ? Sign up to receive the latest short interest report for Ventyx Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVTYX Short Interest Over TimeVTYX Days to Cover Over TimeVTYX Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Ventyx Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,410,000 shares $31.45 million +0.4%14.8%2.2 $3.74 4/15/20248,380,000 shares $39.13 million -9.1%17.5%2.2 $4.67 3/31/20249,220,000 shares $50.71 million -2.4%19.6%2.2 $5.50 3/15/20249,450,000 shares $72.77 million +2.8%20.1%2.2 $7.70 2/29/20249,190,000 shares $65.07 million +64.4%19.5%2.1 $7.08 2/15/20245,590,000 shares $13.98 million +15.0%11.9%1.4 $2.50 Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,860,000 shares $10.25 million -2.4%10.9%1.6 $2.11 1/15/20244,980,000 shares $11.11 million -6.9%11.2%1.6 $2.23 12/31/20235,350,000 shares $13.21 million -26.2%N/A0 $2.47 12/15/20237,250,000 shares $16.31 million -1.5%16.3%2.7 $2.25 11/30/20237,360,000 shares $15.90 million +24.5%16.5%3.2 $2.16 11/15/20235,910,000 shares $13.95 million -20.4%13.3%3 $2.36 10/31/20237,420,000 shares $107.00 million -13.9%17.0%4.9 $14.42 10/15/20238,620,000 shares $159.04 million -7.7%19.7%12.1 $18.45 9/30/20239,340,000 shares $324.38 million -1.5%21.4%15.4 $34.73 9/15/20239,480,000 shares $345.07 million +3.3%21.7%15.9 $36.40 8/31/20239,180,000 shares $307.53 million -1.5%20.7%13.9 $33.50 8/15/20239,320,000 shares $285.66 million -0.1%21.0%13.1 $30.65 7/31/20239,330,000 shares $345.68 million -1.0%22.3%13 $37.05 7/15/20239,420,000 shares $337.61 million -4.0%22.5%12.8 $35.84 6/30/20239,810,000 shares $321.77 million +9.6%24.1%11.9 $32.80 6/15/20238,950,000 shares $299.02 million +8.0%22.1%10.6 $33.41 5/31/20238,290,000 shares $285.76 million +7.1%20.5%10 $34.47 5/15/20237,740,000 shares $278.64 million +6.2%19.2%9.1 $36.00 4/30/20237,290,000 shares $274.10 million +7.1%19.2%8.6 $37.60 4/15/20236,810,000 shares $203.28 million -14.8%18.0%7.4 $29.85 3/31/20237,990,000 shares $267.67 million +37.3%22.5%9.5 $33.50 3/15/20235,820,000 shares $217.67 million +14.6%15.9%7.8 $37.40 2/28/20235,080,000 shares $219.71 million +10.2%14.7%6.7 $43.25 2/15/20234,610,000 shares $206.71 million +27.7%13.3%6.4 $44.84 1/31/20233,610,000 shares $151.62 million -12.6%10.2%5.2 $42.00 1/15/20234,130,000 shares $143.60 million +9.3%11.9%6.9 $34.77 12/30/20223,780,000 shares $123.95 million +0.5%11.0%6.6 $32.79 12/15/20223,760,000 shares $125.77 million +9.6%11.3%6.7 $33.45 11/30/20223,430,000 shares $99.44 million +6.5%11.7%4.7 $28.99 11/15/20223,220,000 shares $83.01 million -13.4%11.3%4.8 $25.78 10/31/20223,720,000 shares $120.42 million -6.8%15.1%5.4 $32.37 10/15/20223,990,000 shares $115.43 million +8.1%18.0%6.2 $28.93 9/30/20223,690,000 shares $128.82 million +5.4%16.7%6.1 $34.91 9/15/20223,500,000 shares $131.32 million -20.1%15.8%6 $37.52Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… VTYX Short Interest - Frequently Asked Questions What is Ventyx Biosciences' current short interest? Short interest is the volume of Ventyx Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 8,410,000 shares of VTYX short. 14.79% of Ventyx Biosciences' shares are currently sold short. Learn More on Ventyx Biosciences' current short interest. What is a good short interest ratio for Ventyx Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTYX shares currently have a short interest ratio of 2.0. Learn More on Ventyx Biosciences's short interest ratio. What is a good short interest percentage for Ventyx Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.79% of Ventyx Biosciences' floating shares are currently sold short. Is Ventyx Biosciences' short interest increasing or decreasing? Ventyx Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 8,410,000 shares, an increase of 0.4% from the previous total of 8,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ventyx Biosciences' float size? Ventyx Biosciences currently has issued a total of 70,500,000 shares. Some of Ventyx Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ventyx Biosciences currently has a public float of 56,850,000 shares. How does Ventyx Biosciences' short interest compare to its competitors? 14.79% of Ventyx Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ventyx Biosciences: Nature's Sunshine Products, Inc. (0.50%), 23andMe Holding Co. (12.81%), CorMedix Inc. (17.94%), Rani Therapeutics Holdings, Inc. (10.88%), Aquestive Therapeutics, Inc. (5.79%), XOMA Co. (2.33%), Vanda Pharmaceuticals Inc. (4.17%), Neoleukin Therapeutics, Inc. (0.35%), Inozyme Pharma, Inc. (8.23%), UroGen Pharma Ltd. (18.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Ventyx Biosciences stock? Short selling VTYX is an investing strategy that aims to generate trading profit from Ventyx Biosciences as its price is falling. VTYX shares are trading up $0.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ventyx Biosciences? A short squeeze for Ventyx Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VTYX, which in turn drives the price of the stock up even further. How often is Ventyx Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTYX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Nature's Sunshine Products Short Interest Data 23andMe Short Interest Data CorMedix Short Interest Data Rani Therapeutics Short Interest Data Aquestive Therapeutics Short Interest Data XOMA Short Interest Data Vanda Pharmaceuticals Short Interest Data Neoleukin Therapeutics Short Interest Data Inozyme Pharma Short Interest Data UroGen Pharma Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTYX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press